The invention discloses the use of sapogenin derivatives in the treatment of cognitive disfunction and similar conditions. Methods of treatment and pharmaceutical compositions are also disclosed.

 
Web www.patentalert.com

< Carboxylic tris-like siloxanyl monomers

> 2,5-disubstituted 3-mercaptopentanoic acid

> Pharmaceutical compositions for the treatment of TNF-.alpha. related disorders

~ 00506